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A Novel Approach for a New Era:  
Successful Integration of Multidisciplinary, Hepatitis C  
Care within an Established HIV Primary Care Practice
Background
Clinical trials have shown that at least 40% of patients with 
chronic hepatitis C (HCV) achieve sustained virologic response 
(SVR) with peginterferon/ribavirin (Peg/RBV). Since patients 
with a history of mental illness, addiction, multiple medical 
 comorbidities or unstable social situations are commonly 
 excluded from research trials, SVR is achieved less often in 
clinical practice. These issues may present management 
 dilemmas for clinicians unaccustomed to the needs of complex 
patients. We proposed that integration of an HCV treatment 
program into an existing multidisciplinary HIV primary care 
practice would better address these needs, resulting in im-
proved treatment outcomes.
Description
An internist-led HCV treatment program was integrated into 
an existing HIV practice in northeastern Pennsylvania employing 
a successful chronic care model, akin to a patient-centered 
medical home. The HIV program was comprised of a multi-
disciplinary team of providers trained in the complex medical 
and psychosocial management of patients with HIV and its 
multiple comorbidities, including the treatment of HCV co-
infection. Certain members of this team subsequently appor-
tioned part of their clinical time to the development of a new 
“Hepatitis Care Center,” focused on the treatment of HCV-
monoinfected patients within the region. 
Principle staff of the new HCV program included general inter-
nists with experience in viral hepatitis management, a licensed 
clinical social worker (LCSW), registered-nurse/case manager 
(RN), dietician, and clinical support staff (MAs, LPN). Fifty per-
cent of the staff was bilingual and bicultural. Intensive patient 
education and adherence support were provided by the RN and 
LCSW, focusing on psychosocial issues, coordination of mental 
health services and resolving barriers to care. Emphasis was 
placed on stabilization of modifiable psychiatric and medical 
comorbidities to allow for initiation of Peg/RBV in patients who 
would not normally receive treatment. Treatment outcomes 
were continually monitored.
Results
•  76 patients initiated Peg/RBV.  None were coinfected with 
HIV.
•  Final outcome data is available in 61 patients.  15 patients 
remain on Peg/RBV.
•  Adverse events (AEs) were typical of Peg/RBV. 
•  Reasons for discontinuation (18, 29%): 
n  Medical (6, 10%): Symptomatic CAD (1), Encephalopathy 
(2), Psoriasis (1), Hepatocellular Carcinoma (1), New Onset 
Type 1 Diabetes/DKA (1)
n  Psychiatric (2, 3%): Depression (1), Aggressive Behavior (1)
n  Other: Self Choice (5, 8%), Addiction (3, 5%), Relocation 
(1), Incarceration (1)
•  SVR was achieved in 35 patients (57%) overall, GT 1 (23, 
51%), GT 2 (6, 86%), GT 3 (4, 67%), GT 4 (1, 50%), and  
GT 6 (1, 100%).
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Conclusions
Integration of HCV monoinfection services into an existing 
multidisciplinary HIV clinical practice resulted in high rates of 
therapy completion and SVR in a diverse patient population. 
Providers experienced in the care of HIV and its many medical 
and psychosocial comorbidities are well poised to manage the 
diverse and complex needs of patients living with HCV in their 
communities. Focusing efforts on education, adherence sup-
port, health stabilization and patient preparedness for treat-
ment allowed Peg/RBV to be provided to a broader population. 
Further evaluation of this model of care is necessary in HIV 
treatment centers and other patient-centered medical homes, 
where medical, case management, mental health, and nutrition 















* No Black patients with genotype 2 HCV were treated.











































 Total Genotype 1 Genotype 2
N=61
Figure 2: Peg/RBV Completion Percentage 
by Race/Ethnicity
Figure 3: SVR by Genotype
Figure 4: SVR by Selected Genotypes* and Race/Ethnicity
